BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 22815256)

  • 1. TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis.
    Matsubara T; Kanto T; Kuroda S; Yoshio S; Higashitani K; Kakita N; Miyazaki M; Sakakibara M; Hiramatsu N; Kasahara A; Tomimaru Y; Tomokuni A; Nagano H; Hayashi N; Takehara T
    Hepatology; 2013 Apr; 57(4):1416-25. PubMed ID: 22815256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tie2-Expressing Monocytes Are Associated with Identification and Prognoses of Hepatitis B Virus Related Hepatocellular Carcinoma after Resection.
    He YF; Wang CQ; Yu Y; Qian J; Song K; Sun QM; Zhou J
    PLoS One; 2015; 10(11):e0143657. PubMed ID: 26599011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
    PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.
    Coffelt SB; Tal AO; Scholz A; De Palma M; Patel S; Urbich C; Biswas SK; Murdoch C; Plate KH; Reiss Y; Lewis CE
    Cancer Res; 2010 Jul; 70(13):5270-80. PubMed ID: 20530679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic inflammation and formation of necrosis in the tumor microenvironment influence patient survival after radical surgery for de novo hepatocellular carcinoma in non-cirrhosis.
    Atanasov G; Dino K; Schierle K; Dietel C; Aust G; Pratschke J; Seehofer D; Schmelzle M; Hau HM
    World J Surg Oncol; 2019 Dec; 17(1):217. PubMed ID: 31830991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Optimal cut-off value of PIVKA-II for diagnosis of hepatocellular carcinoma--using ROC curve].
    Kim MJ; Bae KW; Seo PJ; Jeong IK; Kim JH; Lee BH; Bang KT; Kim DW; Song IH
    Korean J Hepatol; 2006 Sep; 12(3):404-11. PubMed ID: 16998292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma.
    Zhang ZL; Liu ZS; Sun Q
    World J Gastroenterol; 2006 Jul; 12(26):4241-5. PubMed ID: 16830384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R; Wang B; Ding H; Shen H; Li Y; Chen X
    Chin Med J (Engl); 2002 Jan; 115(1):42-5. PubMed ID: 11930656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer.
    Wang X; Zhu Q; Lin Y; Wu L; Wu X; Wang K; He Q; Xu C; Wan X; Wang X
    Br J Cancer; 2017 Oct; 117(9):1371-1382. PubMed ID: 28898232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group.
    Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R
    Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
    Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular mechanism underlying angiogenesis in hepatocellular carcinoma: the imbalance activation of signaling pathways.
    Zhao ZC; Zheng SS; Wan YL; Jia CK; Xie HY
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):529-36. PubMed ID: 14627514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma.
    Matsubara M; Shiraha H; Kataoka J; Iwamuro M; Horiguchi S; Nishina S; Takaoka N; Uemura M; Takaki A; Nakamura S; Kobayashi Y; Nouso K; Yamamoto K
    J Gastroenterol Hepatol; 2012 Oct; 27(10):1602-8. PubMed ID: 22554292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of tumor-infiltrating Tie-2-expressing monocytes in renal cell carcinoma: its relationship to angiogenesis and progression.
    Ji J; Zhang G; Sun B; Yuan H; Huang Y; Zhang J; Wei X; Zhang X; Hou J
    Urology; 2013 Oct; 82(4):974.e9-13. PubMed ID: 23947989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood monocyte subsets predict antiviral response in chronic hepatitis C.
    Rodríguez-Muñoz Y; Martín-Vílchez S; López-Rodríguez R; Hernández-Bartolomé A; Trapero-Marugán M; Borque MJ; Moreno-Otero R; Sanz-Cameno P
    Aliment Pharmacol Ther; 2011 Oct; 34(8):960-71. PubMed ID: 21848603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.
    Nakamura S; Nouso K; Sakaguchi K; Ito YM; Ohashi Y; Kobayashi Y; Toshikuni N; Tanaka H; Miyake Y; Matsumoto E; Shiratori Y
    Am J Gastroenterol; 2006 Sep; 101(9):2038-43. PubMed ID: 16848811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
    Mukozu T; Nagai H; Matsui D; Kanekawa T; Sumino Y
    Anticancer Res; 2013 Mar; 33(3):1013-21. PubMed ID: 23482775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of TIE2-expressing monocytes in hilar cholangiocarcinoma.
    Atanasov G; Hau HM; Dietel C; Benzing C; Krenzien F; Brandl A; Englisch JP; Wiltberger G; Schierle K; Robson SC; Reutzel-Selke A; Jonas S; Pascher A; Pratschke J; Schmelzle M
    J Surg Oncol; 2016 Jul; 114(1):91-8. PubMed ID: 27111031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.
    Tateishi R; Shiina S; Yoshida H; Teratani T; Obi S; Yamashiki N; Yoshida H; Akamatsu M; Kawabe T; Omata M
    Hepatology; 2006 Dec; 44(6):1518-27. PubMed ID: 17133456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis.
    Germano D; Daniele B
    Hepatobiliary Surg Nutr; 2014 Aug; 3(4):166-7. PubMed ID: 25202690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.